期刊文献+

冠状动脉迂曲与室间隔肥厚型心肌病患者不良预后的相关性分析 被引量:1

Correlation between coronary artery tortuosity and poor prognosis in patients with septal hypertrophic cardiomyopathy
原文传递
导出
摘要 目的:探讨室间隔肥厚型心肌病(HCM)患者中冠状动脉(冠脉)迂曲的发生率及其与不良预后的相关性。方法:本研究为回顾性队列研究。选取2017年12月1日至2021年6月10日在阜外华中心血管病医院和郑州大学人民医院住院的室间隔HCM患者,根据性别、年龄、有无高血压1∶1配对非HCM患者作为对照组。按照有无冠脉迂曲将室间隔HCM组分为冠脉迂曲组和非冠脉迂曲组。比较室间隔HCM组和对照组患者基线临床资料和冠脉造影结果,采用多因素logistic分析导致冠脉迂曲的危险因素。随访室间隔HCM患者至2022年7月1日,主要终点事件是恶性心律失常、缺血性卒中、全因死亡的复合终点,比较冠脉迂曲组和非冠脉迂曲组主要终点事件发病密度,采用Cox风险比例回归模型分析影响室间隔HCM患者终点事件的危险因素。结果:室间隔HCM组和对照组各156例患者,年龄均为(57.0±11.4)岁,两组女性各75例(48.1%)。室间隔HCM组冠脉迂曲发生率高于对照组(63.5%比36.5%, P<0.01),冠脉迂曲评分高于对照组( P<0.01)。多因素logistic回归分析结果显示室间隔HCM是导致冠脉迂曲的危险因素( OR=3.27,95% CI:2.02~5.29, P<0.01)。经过(2.5±1.2)年随访,室间隔HCM患者中,冠脉迂曲组主要终点事件发病密度高于非冠脉迂曲组( P=0.02),冠脉迂曲评分每升高1分增加室间隔HCM患者53%的主要终点事件风险( HR=1.53,95% CI:1.26~1.86, P<0.01)。 结论:室间隔HCM患者易伴发冠脉迂曲,且程度更重;冠脉迂曲是室间隔HCM患者出现不良事件的危险因素。 ObjectiveTo investigate the incidence of coronary artery tortuosity and its correlation with poor prognosis in patients with septal hypertrophic cardiomyopathy(HCM).MethodsThis was a retrospective cohort study.Patients with septal HCM who were hospitalized in Fuwai Central China Cardiovascular Hospital and Zhengzhou University People′s Hospital between December 1,2017 and June 10,2021 were selected.Non-HCM patients were matched by gender,age,and hypertension as control group.Septal HCM was divided into two groups based on the presence or absence of coronary artery tortuosity.Clinical baseline data and coronary angiography findings were compared using a multifactorial logistic analysis of the risk factors for coronary artery tortuosity.Patients were followed up until July 1,2022,with the primary outcome being the composite endpoint of malignant arrhythmia,ischemic stroke and all-cause death.Incidence densities were compared between the coronary artery tortuosity and non-coronary artery tortuosity groups of septal HCM patients.The Cox risk-ratio model was used to analyze risk factors for primary outcomes in septal HCM patients.ResultsThere were 156 patients in the septal HCM group and 156 patients in the control group,both aged(57.0±11.4)years,and 75(48.1%)were female.The incidence of coronary artery tortuosity was significantly higher in the septal HCM group than in the control group(63.5%vs.36.5%,P<0.01),and the coronary artery tortuosity score was also higher in the septal HCM group than in the control group(P<0.01).Multiple logistic regression analysis showed that septal HCM was a risk factor for coronary artery tortuosity(OR=3.27,95%CI:2.02-5.29,P<0.01).In the septal HCM patients,after(2.5±1.2)years of follow-up,the incidence density of primary outcome was significantly higher in the coronary artery tortuosity group than in the non-coronary artery tortuosity group(P=0.02),while each on-point in coronary artery tortuosity score increased the risk of primary outcome by 53%for septal HCM patients(HR=1.53,95%CI:1.26-1.86,P<0.01).ConclusionsPatients with septal HCM are more prone to suffer coronary artery tortuosity and suffer from it to a greater extent.Coronary artery tortuosity is an important risk factor for adverse events in patients with septal HCM.
作者 黄一 李文涛 张优 王山 林青 李牧蔚 朱中玉 王宪沛 高传玉 Huang Yi;Li Wentao;Zhang You;Wang Shan;Lin Qing;Li Muwei;Zhu Zhongyu;Wang Xianpei;Gao Chuanyu(Department of Cardiology,Zhengzhou University Central China Fuwai Hospital,Fuwai Central China Cardiovascular Hospital,Zhengzhou 450003,China;Department of Cardiology,Zhengzhou University People′s Hospital,Zhengzhou 450001,China;Henan Institute of Cardiovascular Epidemiology,Zhengzhou University Central China Fuwai Hospital,Zhengzhou 450003,China;Department of Radiology,Zhengzhou University Central China Fuwai Hospital,Fuwai Central China Cardiovascular Hospital,Zhengzhou 450003,China)
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2024年第7期798-805,共8页 Chinese Journal of Cardiology
关键词 肥厚型心肌病 室间隔 冠状动脉 迂曲 预后 冠状动脉迂曲评分 危险因素 Hypertrophic cardiomyopathy Ventricular septal Coronary artery Tortuosity Prognosis Coronary artery tortuosity score Risk factors
  • 相关文献

参考文献5

二级参考文献26

  • 1中国医师协会心力衰竭专业委员会,中华心力衰竭和心肌病杂志编辑委员会,张健,黄峻.中国肥厚型心肌病管理指南2017[J].中华心力衰竭和心肌病杂志(中英文),2017,1(2):65-86. 被引量:35
  • 2朱淑贤,钱菊英.冠状动脉微循环灌注障碍和冠脉无复流机理研究[J].微循环技术杂志(临床与实验),2004,8(5):267-269. 被引量:17
  • 3陈灏珠.实用内科学.12版.北京:人民卫生出版社,2005:1866-1869
  • 4Maron BJ. Hypertrophic cardiomyopathy : systematic review. JAMA ,2002,287 (10) : 1308-1320.
  • 5Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation, 1996, 93 (5) :841-842.
  • 6Maron B J, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol,1981,48(3) :418-428.
  • 7Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation, 2000,102 ( 8 ) : 858-564.
  • 8Elliott PM, Poloniecki J, Dickie S, et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol, 2000,36(7) :2212-2218.
  • 9Sorajja P, Ommen SR, Nishimura RA, et al. Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation ,2003,108 (9):2342-2348.
  • 10Olivotto I, Maron MS, Adabag AS, et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol, 2005, 46 (3): 480-487.

共引文献268

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部